Drug application
NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN, TRIAMCINOLONE ACETONIDE)
Drugs@FDA ANDA 208300 · GLENMARK PHARMS LTD
Key facts
| Drug name | NYSTATIN AND TRIAMCINOLONE ACETONIDE |
|---|---|
| Active ingredients | NYSTATIN, TRIAMCINOLONE ACETONIDE |
| Application type | ANDA |
| Application number | 208300 |
| Company | GLENMARK PHARMS LTD |
| Dosage forms | OINTMENT, TOPICAL |
| Strength | 100,000 UNITS/GM;0.1% |
| Marketing status | Discontinued |
| TE codes | AT |
| Reference listed drug | No |
| Latest submission status date | Jun 23, 2016 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.